Trump pushed tariffs on Canada to 35 per cent, but a CUSMA carveout creates a shield
Loading the player instance is taking more time than usual
WASHINGTON — U.S. President Donald Trump has increased tariffs on Canada to a staggering 35 per cent but a critical carveout is likely to shield most goods from the devastating duties.
The White House has said the tariffs won't be applied to goods that are compliant with the Canada-U.S.-Mexico Agreement on trade, also known as CUSMA.
Here's what that means for Canadian companies:
What is CUSMA compliance?
CUSMA was negotiated during the first Trump administration to replace the North American Free Trade Agreement.
Companies can claim preferential treatment under CUSMA if they meet its rules of origin. While it is different depending on the product, generally it requires a specific amount of the goods be made of products or with labour originating from Canada, Mexico or the United States.
About 80 to 90 per cent of Canadian goods might be able to comply with CUSMA's rules of origin, said Michael Dobner, the national leader of economics and policy practice at PricewaterhouseCoopers Canada.
Not all exporters have filed the necessary paperwork to avoid the duties.
There's been an increase in businesses claiming preferential treatment under CUSMA but it's not clear exactly how much of Canadian exports are currently compliant.
Are any industries more at risk?
Dobner said there's no specific industry that he expects to be hit the hardest.
Certain companies may not be able to source input materials from North America to make their product. That means they would not be able to apply for preferential treatment under CUSMA and will face the 35 per cent tariff.
But Dobner said 'it's the minority of the exports of Canada to the U.S.'
What's the impact on small and medium-sized businesses?
Small and medium-sized businesses may have not applied for CUSMA preferential status before Trump's tariffs because the process can be burdensome for enterprises of that size.
Some small and medium-sized businesses might not meet CUSMA rules of origin requirements and don't have the financial flexibility to change their inputs to North American products.
Dan Kelly, president and CEO of the Canadian Federation of Independent Business, said many of these businesses were absorbing some or all of the costs associated with Trump's tariffs under the assumption that there would a resolution coming.
Kelly said some small and medium-sized businesses facing the 35 per cent tariff may have to stop selling into the United States.
This report by The Canadian Press was first published Aug. 1, 2025.
Kelly Geraldine Malone, The Canadian Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
17 minutes ago
- Winnipeg Free Press
What to know about how Trump's judicial picks could reshape abortion rights for decades
CHICAGO (AP) — A review by The Associated Press shows that several of President Donald Trump's nominees to the federal courts have revealed anti-abortion views, been associated with anti-abortion groups or defended abortion restrictions. Several have helped defend their state's abortion restrictions in court and some have been involved in cases with national impact, including on access to medication abortion. While Trump has said issues related to abortion should be left to the states, the nominees, with lifetime appointments, would be in position to roll back abortion rights long after Trump leaves the White House. Trump has been inconsistent on abortion Trump has repeatedly shifted his messaging on abortion, often giving contradictory or vague answers. In the years before his most recent presidential campaign, Trump had voiced support for a federal ban on abortion on or after 20 weeks in pregnancy and said he might support a national ban around 15 weeks. He later settled on messaging that decisions about abortion access should be left to the states. Throughout his campaign, Trump has alternated between taking credit for appointing the Supreme Court justices who helped overturn Roe v. Wade and striking a more neutral tone. That's been an effort to navigate the political divide between his base of anti-abortion supporters and the broader public, which largely supports access to abortion. Many nominees have anti-abortion backgrounds One Trump nominee called abortion a 'barbaric practice' while another referred to himself as a 'zealot' for the anti-abortion movement. A nominee from Tennessee said abortion deserves special scrutiny because 'this is the only medical procedure that terminates a life.' One from Missouri spread misinformation about medication abortion, including that it 'starves the baby to death in the womb' in a lawsuit aiming to challenge the Food and Drug Administration's approval of the abortion pill mifepristone. Legal experts and abortion rights advocates warn of a methodical remaking of the federal courts in a way that could pose enduring threats to abortion access nationwide. Bernadette Meyler, a professor of constitutional law at Stanford University, said judicial appointments 'are a way of federally shaping the abortion question without going through Congress or making a big, explicit statement.' 'It's a way to cover up a little bit what is happening in the abortion sphere compared to legislation or executive orders that may be more visible, dramatic and spark more backlash,' she said. The nominees represent Trump's 'promises' to Americans, White House says Harrison Fields, a White House spokesperson, said 'every nominee of the President represents his promises to the American people and aligns with the U.S. Supreme Court's landmark ruling.' 'The Democrats' extreme position on abortion was rejected in November in favor of President Trump's commonsense approach, which allows states to decide, supports the sanctity of human life, and prevents taxpayer funding of abortion,' Fields said in a statement to the AP. Trump focused primarily on the economy and immigration during his 2024 campaign, the issues that surveys showed were the most important topics for voters. Anti-abortion groups, abortion rights advocates respond Anti-abortion advocates say it's premature to determine whether the nominees will support their objectives but that they're hopeful based on the names put forth so far. 'We look forward to four more years of nominees cut from that mold,' said Katie Glenn Daniel, director of legal affairs for the national anti-abortion organization SBA Pro-Life America. Abortion rights advocates said Trump is embedding abortion opponents into the judiciary one judge at a time 'This just feeds into this larger strategy where Trump has gotten away with distancing himself from abortion, saying he's going to leave it to the states, while simultaneously appointing anti-abortion extremists at all levels of government,' said Mini Timmaraju, president of the national abortion rights organization Reproductive Freedom for All.
Globe and Mail
27 minutes ago
- Globe and Mail
2 Surefire Stocks to Invest $1,000 in for the Long Haul
Key Points Alphabet can overcome an antitrust challenge thanks to strong growth prospects and substantial cash flow. Intuitive Surgical leads its niche of the medical device market and still has ample whitespace ahead. 10 stocks we like better than Alphabet › Investing in stocks is both accessible to the general public and likely to yield strong returns over the long term. That's what makes it one of the best ways to increase your wealth. However, putting your money in the right stocks is crucial. Some companies may turn out to be terrible investments, as they significantly lag behind the market and may even cease to exist. Investors can avoid that fate by investing in ETFs that track major indexes or by selecting stocks that have the potential to outperform broader equities over extended periods. These are typically well-established, highly profitable companies with solid businesses, excellent prospects, and strong competitive edges. Here are two brilliant examples: Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL), and Intuitive Surgical (NASDAQ: ISRG). Here's why putting $1,000 into either of those stocks would be a great move. 1. Alphabet Alphabet has been one of the more undervalued among the trillion-dollar tech leaders of late. In fairness, that's because it faces some potential headwinds related to antitrust lawsuits in the U.S. Regulators want the company to relinquish its Chrome browser, a key component of its advertising business. While that's worth keeping an eye on, Alphabet continues to impress with its financial results. The company's second-quarter earnings were no different. The tech giant grew its revenue by 14% year over year to $96.4 billion, while its net earnings per share (EPS) of $2.31 were up 22.2% compared to the year-ago period. Some of Alphabet's current growth drivers, including cloud computing and artificial intelligence (AI), should remain so for many years to come. The company pointed out that its cloud division, Google Cloud, now has a revenue run rate of more than $50 billion. Though Alphabet's advertising business remains its main cash cow, cloud and AI could take over in the next decade. Investors should be excited about that since it will mean that the company will become far less reliant on its advertising business, which would take the biggest hit if Alphabet loses Chrome. So, the more diversified the business becomes, the less of a risk this potential worst-case scenario of losing Chrome is. Furthermore, Alphabet is exploring other potential opportunities, including streaming through YouTube, a leader in that niche, and self-driving cars through its subsidiary, Waymo. Lastly, Alphabet has a strong competitive edge from multiple sources, including Google's network effect and strong brand name, as well as the switching costs associated with its cloud solutions. Alphabet is firing on all cylinders, and the company's long-term prospects remain bright. Even if regulators in the U.S. succeed in forcing the company to relinquish its Chrome browser, Alphabet should recover due to having multiple lucrative opportunities and significant amounts of free cash flow -- to the tune of $5.3 billion as of the end of the second quarter. That's significantly lower than the $13.5 billion it had as of the end of Q2 2024, but that's partly because Alphabet is reinvesting substantial amounts, including a projected $85 billion this year, into capital expenditures to support various growth opportunities. This investment could pay for itself several times over in the long run as the company makes further progress in cloud, AI, and other areas. Alphabet remains well-positioned to outperform the market over the next decade. Investors can get five of the company's shares for $1,000. 2. Intuitive Surgical Intuitive Surgical, the leader in the robotic-assisted surgery (RAS) market, has struggled this year. Trump's aggressive tariffs could take a bite out of the company's earnings, which is why many investors are choosing to stay away from the stock. However, the medical device specialist's outlook is still strong, at least for investors willing to be patient. For one, Intuitive Surgical continues to record excellent financial results. The company's second-quarter revenue was $2.44 billion, 21% higher than the year-ago period, thanks to a 17% year-over-year increase in the number of procedures performed with its crown jewel, the Da Vinci System. Intuitive Surgical's adjusted EPS came in at $2.19, 23% higher than Q2 2024. The company has had little competition in the RAS field, and although that's about to change, several factors should allow it to perform well over the next decade. First, it will be challenging for newcomers to catch up, as Intuitive Surgical has been earning indications for the Da Vinci System for years. It is approved for use in general surgeries, bariatric procedures, urologic procedures, gynecologic procedures, and more. Second, since the Da Vinci System is expensive and requires a learning curve, after putting considerable time and money into acquiring one and training medical staff on it, healthcare facilities will need a lot of convincing to switch to a competitor. In other words, Intuitive Surgical benefits from high switching costs. Third, the company is an innovator. It earned clearance for the fifth generation of its crown jewel last year and will undoubtedly continue to improve the device. Lastly, there is significant whitespace in the RAS market. Intuitive Surgical will benefit from the world's aging population, as older individuals are more likely to require many of the procedures performed with its Da Vinci system. Even with the current volume of surgeries, RAS procedures have captured only 5% of those eligible for robotic surgery. That points to a massive opportunity, and as a leader in the market, Intuitive Surgical should benefit. The stock may be down this year, but it could deliver superior returns over the long run. With $1,000, investors can purchase two shares. Should you invest $1,000 in Alphabet right now? Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
Nepal's LGBTQ+ community holds first Pride rally since US funding cuts
KATHMANDU, Nepal (AP) — Members of the Nepal's LGBTQ+ community and supporters rallied in the capital Sunday in the annual pride rally, which was the first since a major cut in funding after the U.S. government ceased financial aid. Hundreds of people took part in the rally through the heart of Kathmandu, playing music and dancing in the Gai Jatra festival, which is celebrated to remember family members who have passed away during the year. But it has long drawn colorful parades by bringing in sexual minorities to join in on the festivities. Nepal's LGBTQ+ campaign has been hit after U.S. President Donald Trump's administration began dismantling the U.S. Agency for International Development, which was responsible for humanitarian aid. Most of the help centers for Nepal's LGBTQ+ community have been closed because of a lack of funds. Thousands of people have been left without support. In the past few years, Nepal's LGBTQ+ community made rapid advancements in securing their rights. The nation became one of the first in Asia to allow same sex-sex marriage. The constitution adopted in 2015 explicitly stated there can be no discrimination on the basis of sexual orientation. The U.S. was among the biggest donors for the LGBTQ+ rights campaign. Over the years, USAID and others stepped in and partnered with help centers to support initiatives like HIV prevention and care, and safe-sex counselling. The U.S. funds were vital for running the centers and clinics that helped with distributing free condoms, screenings and follow-up treatment for people with HIV. Now the USAID office in Nepal is closed. 'Because of the cut in funding many of the services we have been providing to the community have been hit badly, but we are not discouraged but are hopeful we will get alternative sources and fundings to help us restart those services,' said Simran Sherchan, a LGBTQ+ rights activist in the rally.
